Keensight Capital acquires majority stake in Isto Biologics, a leading orthobiologics player, from Thompson Street Capital Partners

Keensight Capital acquires majority stake in Isto Biologics, a leading orthobiologics player, from Thompson Street Capital Partners
Sep 17, 2025 9:08:36 AM
3
min read